Latest Tumor suppressor genes Stories
BRCA Share(TM) is a novel public-private initiative designed to enhance the clarity and quality of patient testing MADISON, N.J.
Unique delivery vehicle to be developed across p53 mutated solid tumors by delivering wild type p21 NEW YORK and ZUG, Switzerland, April 15, 2015 /PRNewswire/ -- SELLAS Life Sciences
Study Results Highlight Molecular Similarities and Differences between Uterine Papillary and Ovarian Serous Carcinomas, and between Epithelial Ovarian and Endometrial Cancers IRVING,
A landmark DNA study in Iceland has resulted in an unprecedented look at an entire country’s genetic makeup, discovering several previously unknown mutations that could cause a vast array of different health problems, but regulations prevent some of that data from being used.
A magnetic resonance spectroscopy technique that monitors biochemical changes in tissue could improve the management of women at risk of breast cancer, according to a new study published online,
Goal of Enabling Affordable, Large-Scale BRCA1 and BRCA2 Screening for General Population FREMONT, Calif., Feb. 19, 2015 /PRNewswire/ -- WaferGen Bio-systems, Inc.
Agreement ensures continuing broad patient access to Quest's BRCAvantage(TM) services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb.
-- Findings could lead to new therapies for breast, ovarian, and other cancers NEW YORK, Feb.
UC Davis researchers have uncovered a complex interaction between the proteins Rbm38 and p53 that governs tumor suppression and aging Sacramento, Calif.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.